L'équipe du département de pharmacologie

DOMAINES

CONTACT

 

 

 

Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
fren

PUBLICATIONS 2013

Dernière mise à jour des publications: 2019-10-07

  1. [Analyze and use the results of clinical studies in the context of good use. Critical analysis, clinical research and levels of evidence].
    Rev Prat. 2013 (63-9) 1305-10
    Pariente A.
     PubMed citation

  2. Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort.
    Target Oncol. 2013
    Fourrier-Réglat A, Smith D, Rouyer M, Bénichou J, Guimbaud R, Bécouarn Y, Bernard O, Noize P, Moore N, Ravaud A; on behalf of the ETNA study group.
     PubMed citation

  3. [Drug safety. Why and how? "All drugs are dangerous, some are also useful"]
    Prog Urol. 2013 (23-15) 1213-5
    Moore N.
     PubMed citation

  4. Usage patterns of "over the counter" versus prescription-strength non-steroidal anti-inflammatory drugs in France.
    Br J Clin Pharmacol. 2013
    Duong M, Salvo F, Pariente A, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N..
     PubMed citation

  5. Relative risks from case-population data.
    Epidemiology. 2013 (24-6) 935-6
    Moore N, Gulmez SE, Blin P, Lassalle R, Jove J, Théophile H, Bégaud B, Larrey D, Bénichou J..
     PubMed citation

  6. Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.
    Expert Rev Clin Pharmacol. 2013 (6(5)) 503-17
    Molimard M, D'Andrea P.
     PubMed citation

  7. Observation of the long-term effects of lifestyle intervention during balneotherapy in metabolic syndrome.
    Therapie. 2013 (68-3) 163-7
    Gin H, Demeaux JL, Grelaud A, Grolleau A, Droz-Perroteau C, Robinson P, Lassalle R, Abouelfath A, Boisseau M, Toussaint C, Moore N..
     PubMed citation

  8. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
    Drug Saf. 2013 (36-10) 1033-44
    Théophile H, André M, Miremont-Salamé G, Arimone Y, Bégaud B.
     PubMed citation

  9. Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT).
    Drug Saf. 2013
    Gulmez SE, Moore N, Pageaux GP, Lignot S, Horsmans Y, Stricker B, Bernuau J, Bissoli F, Thorburn D, Montastruc JL, Micon S, Hamoud F, Lassalle R, Jové J, Blin P, Larrey D..
     PubMed citation

  10. Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy.
    Antivir Ther. 2013 (18-5) 723-7
    Trimoulet P, Pinson P, Papuchon J, Foucher J, Vergniol J, Chermak F, Wittkop L, Castaing N, Merrouche W, Reigadas S, Molimard M, Kann M, Fleury H, de Lédinghen V..
     PubMed citation

  11. A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.
    Drug Saf. 2013 (36-7) 565-72
    Salvo F, Leborgne F, Thiessard F, Moore N, Bégaud B, Pariente A.
     PubMed citation

  12. The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.
    Eur J Clin Pharmacol. 2013 (69-sup1) 33-41
    Moore N.
     PubMed citation

  13. Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.
    BMC Endocr Disord. 2013 (13-1) 15
    Guelfucci F, Clay E, Aballéa S, Lassalle R, Moore N, Toumi M..
     PubMed citation

  14. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies
    Pharmacoepidemiol Drug Saf. 2013 (22-6) 559-70
    Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S.
     PubMed citation

  15. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.
    Drug Saf. 2013 (36-4) 217-30
    Boyer A, Gruson D, Bouchet S, Clouzeau B, Hoang-Nam B, Vargas F, Gilles H, Molimard M, Rogues AM, Moore N.
     PubMed citation

  16. Is paracetamol hepatotoxic at normal doses?
    BMJ. 2013 (346) f1519
    Moore ND, Gulmez E, Blin P.
     PubMed citation

  17. Attitudes and opinion about adverse drug events of women living in a city of south Italy
    Pharmacology. 2013 (91-(3-4)) 173-7
    Salvo F, Miroddi M, Alibrandi A, Calapai F, Cafeo V, Mancari F, Gangemi S, Caputi AP, Calapai G.
     PubMed citation

  18. Prescription of Antiepileptics and the Risk of Road Traffic Crash.
    J Clin Pharmacol. 2013 1-8
    Orriols L, Foubert-Samier A, Gadegbeku B, Delorme B, Tricotel A, Philip P, ... Lagarde E.
     PubMed citation

  19. A few clarifications please.
    BMJ. 2013 (346) f1015
    Moore ND.
     PubMed citation

  20. From in vitro to in vivo: intracellular determination of imatinib and nilotinib may be related with clinical outcome.
    Leukemia. 2013
    Bouchet S, Dulucq S, Pasquet JM, Lagarde V, Molimard M, Mahon FX.
     PubMed citation

  21. Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen): The Multinational Case-Population SALT Study.
    Drug Saf. 2013 (36-2) 135-44
    Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jove J, ... Moore N.
     PubMed citation

  22. Double blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile hemangiomas in infants less than 4 months of age.
    Br J Dermatol. 2013 (169-1) 181-3
    Léauté-Labrèze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, Ezzedine K, Moore N.
     PubMed citation

  23. Ca2+-Activated K+ Channel-3.1 Blocker TRAM-34 Attenuates Airway Remodeling and Eosinophilia in a Murine Asthma Model.
    Am J Respir Cell Mol Biol. 2013 (48-2) 212-9
    Girodet PO, Ozier A, Carvalho G, Ilina O, Ousova O, Gadeau AP, ... Berger P.
     PubMed citation

  24. Acute and sub-chronic (28days) oral toxicity evaluation of hydroethanolic extract of Bridelia ferruginea Benth root bark in male rodent animals.
    Food Chem Toxicol. 2013 (52C) 176-179
    Bakoma B, Berke B, Eklu-Gadegbeku K, Agbonon A, Aklikokou K, Gbeassor M, ... Moore N.
     PubMed citation

  25. Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project.
    J Am Med Inform Assoc. 2013 (20-3) 446-52
    Avillach P, Dufour JC, Diallo G, Salvo F, Joubert M, Thiessard F, Mougin F, Trifirò G, Fourrier-Réglat A, Pariente A, Fieschi M.
     PubMed citation

  26. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.
    Pharmacoepidemiol Drug Saf. 2013 (22-2) 160-7
    Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, ... Begaud B.
     PubMed citation

  27. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.
    J Am Med Inform Assoc. 2013 (20-1) 184-192
    Avillach P, Coloma PM, Gini R, Schuemie M, Mougin F, Dufour JC, ... Trifiro G.
     PubMed citation

  28. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT).
    Eur J Clin Pharmacol. 2013 (69-3) 605-16
    Gulmez SE, Larrey D, Pageaux GP, Lignot-Maleyran S, de Vries C, Sturkenboom M, ... Moore N.
     PubMed citation

  29. Characteristics associated with use of homeopathic drugs for psychiatric symptoms in the general population.
    Eur Psychiatry. 2013 (28-2) 110-6
    Grolleau A, Begaud B Verdoux H.
     PubMed citation

  30. Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort study.
    Fundam Clin Pharmacol. 2013 (27-1) 113-9
    Smith D, Terrebonne E, Rouyer M, Blanc JF, Breilh D, Pedeboscq S, ... Fourrier-Reglat A.
     PubMed citation